245 related articles for article (PubMed ID: 1596288)
1. Binding of [3H]bryostatin 4 to protein kinase C.
Lewin NE; Dell'Aquila ML; Pettit GR; Blumberg PM; Warren BS
Biochem Pharmacol; 1992 May; 43(9):2007-14. PubMed ID: 1596288
[TBL] [Abstract][Full Text] [Related]
2. Binding of [26-3H]bryostatin 1 and analogs to calcium-dependent and calcium-independent protein kinase C isozymes.
Kazanietz MG; Lewin NE; Gao F; Pettit GR; Blumberg PM
Mol Pharmacol; 1994 Aug; 46(2):374-9. PubMed ID: 8078499
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of sub-nanomolar affinity of bryostatin 1 for the phorbol ester receptor in rat brain.
de Vries DJ; Herald CL; Pettit GR; Blumberg PM
Biochem Pharmacol; 1988 Nov; 37(21):4069-73. PubMed ID: 3190746
[TBL] [Abstract][Full Text] [Related]
4. Contrasting duration of inhibition of cell-cell communication in primary mouse epidermal cells by phorbol 12,13-dibutyrate and by bryostatin 1.
Pasti G; Rivedal E; Yuspa SH; Herald CL; Pettit GR; Blumberg PM
Cancer Res; 1988 Jan; 48(2):447-51. PubMed ID: 3422054
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1.
Basu A; Lazo JS
Cancer Res; 1992 Jun; 52(11):3119-24. PubMed ID: 1591725
[TBL] [Abstract][Full Text] [Related]
6. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
Jalava AM; Heikkilä J; Akerlind G; Pettit GR; Akerman KE
Cancer Res; 1990 Jun; 50(11):3422-8. PubMed ID: 2334938
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the cysteine-rich region of the Caenorhabditis elegans protein Unc-13 as a high affinity phorbol ester receptor. Analysis of ligand-binding interactions, lipid cofactor requirements, and inhibitor sensitivity.
Kazanietz MG; Lewin NE; Bruns JD; Blumberg PM
J Biol Chem; 1995 May; 270(18):10777-83. PubMed ID: 7537738
[TBL] [Abstract][Full Text] [Related]
8. Residues in the second cysteine-rich region of protein kinase C delta relevant to phorbol ester binding as revealed by site-directed mutagenesis.
Kazanietz MG; Wang S; Milne GW; Lewin NE; Liu HL; Blumberg PM
J Biol Chem; 1995 Sep; 270(37):21852-9. PubMed ID: 7665608
[TBL] [Abstract][Full Text] [Related]
9. Biological activity of 26-succinylbryostatin 1.
Bignami GS; Wagner F; Grothaus PG; Rustagi P; Davis DE; Kraft AS
Biochim Biophys Acta; 1996 Jul; 1312(3):197-206. PubMed ID: 8703988
[TBL] [Abstract][Full Text] [Related]
10. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM
Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts.
Szallasi Z; Smith CB; Pettit GR; Blumberg PM
J Biol Chem; 1994 Jan; 269(3):2118-24. PubMed ID: 8294465
[TBL] [Abstract][Full Text] [Related]
12. Ligand structure-activity requirements and phospholipid dependence for the binding of phorbol esters to protein kinase D.
Wang QJ; Fang TW; Yang D; Lewin NE; Van Lint J; Marquez VE; Blumberg PM
Mol Pharmacol; 2003 Dec; 64(6):1342-8. PubMed ID: 14645664
[TBL] [Abstract][Full Text] [Related]
13. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
Szallasi Z; Denning MF; Smith CB; Dlugosz AA; Yuspa SH; Pettit GR; Blumberg PM
Mol Pharmacol; 1994 Nov; 46(5):840-50. PubMed ID: 7969070
[TBL] [Abstract][Full Text] [Related]
14. Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C.
Wender PA; Cribbs CM; Koehler KF; Sharkey NA; Herald CL; Kamano Y; Pettit GR; Blumberg PM
Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7197-201. PubMed ID: 3174627
[TBL] [Abstract][Full Text] [Related]
15. Partial parallelism and partial blockade by bryostatin 1 of effects of phorbol ester tumor promoters on primary mouse epidermal cells.
Sako T; Yuspa SH; Herald CL; Pettit GR; Blumberg PM
Cancer Res; 1987 Oct; 47(20):5445-50. PubMed ID: 2888531
[TBL] [Abstract][Full Text] [Related]
16. Effect of pharmacologic manipulation of protein kinase C by phorbol dibutyrate and bryostatin 1 on the clonogenic response of human granulocyte-macrophage progenitors to recombinant GM-CSF.
McCrady CW; Staniswalis J; Pettit GR; Howe C; Grant S
Br J Haematol; 1991 Jan; 77(1):5-15. PubMed ID: 1998597
[TBL] [Abstract][Full Text] [Related]
17. Zinc finger domains and phorbol ester pharmacophore. Analysis of binding to mutated form of protein kinase C zeta and the vav and c-raf proto-oncogene products.
Kazanietz MG; Bustelo XR; Barbacid M; Kolch W; Mischak H; Wong G; Pettit GR; Bruns JD; Blumberg PM
J Biol Chem; 1994 Apr; 269(15):11590-4. PubMed ID: 8157692
[TBL] [Abstract][Full Text] [Related]
18. Binding of [26-3H]-epi-bryostatin 4 to protein kinase C.
Lewin NE; Pettit GR; Kamano Y; Blumberg PM
Cancer Commun; 1991 Mar; 3(3):67-70. PubMed ID: 2001329
[TBL] [Abstract][Full Text] [Related]
19. Three activators of protein kinase C, bryostatins, dioleins, and phorbol esters, show differing specificities of action on GH4 pituitary cells.
Ramsdell JS; Pettit GR; Tashjian AH
J Biol Chem; 1986 Dec; 261(36):17073-80. PubMed ID: 3465727
[TBL] [Abstract][Full Text] [Related]
20. Bryostatins selectively regulate protein kinase C-mediated effects on GH4 cell proliferation.
Mackanos EA; Pettit GR; Ramsdell JS
J Biol Chem; 1991 Jun; 266(17):11205-12. PubMed ID: 1904062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
